Follow Synopsys to never miss an important update.
HSBC upgraded its view on Synopsys from Hold to Buy, setting a price target of $700. This is well above the average analyst target of $558 and suggests the firm sees significant room for the stock to rise from its current price of about $420.
This upgrade from a major global bank reflects growing confidence in the company's role as a vital provider of the software needed to design AI chips. When a widely followed firm like HSBC changes its rating, it often signals that the market's view of the company's long-term growth is shifting for the better.
Source: HSBC
Synopsys launched its Autopilot platform, which uses AI agents to help engineers plan and execute chip designs more quickly. These tools are designed to handle long-term engineering tasks that usually require constant human oversight, which can help customers get higher-quality chips to market faster.
This launch is a key part of the company's strategy to use AI to make its software more essential. As chips become more complex, engineers can no longer keep up using old methods. By automating the hardest parts of the design process, Synopsys can justify higher prices for its tools while making it even harder for customers to switch to rivals.
Source: PRNewsWire
BNP Paribas raised its rating on Synopsys from Underperform to Neutral on Thursday. The firm set a price target of $420, which is slightly below where the stock currently trades. This move suggests the analyst no longer sees the stock as likely to fall behind the broader market, even if they aren't yet ready to call it a buy.
While this specific firm is more cautious, most Wall Street analysts remain more optimistic about the company. The average price target across all firms is about $558, reflecting a general view that Synopsys will continue to benefit as tech giants spend more on the software tools needed to design custom AI chips.
Source: BNP Paribas
Synopsys is expanding its partnership with TSMC, the company that manufactures chips for giants like Apple and Nvidia. The collaboration focuses on A14, which is an upcoming, highly advanced method for making even smaller and more efficient transistors. They are also developing "agentic AI" tools, which are software assistants that can handle complex engineering tasks automatically to help designers work faster.
This matters because as chips become more difficult to design, engineers rely more heavily on Synopsys software to ensure the hardware actually works before it is built. By aligning its tools with TSMC's newest manufacturing processes early, Synopsys ensures it remains the default choice for companies building the next wave of high-performance AI processors.
Source: PRNewsWire
Wells Fargo upgraded the stock to its highest rating, setting a price target of $475. This follows similar upgrades from Morgan Stanley and Baird earlier this month, as several analysts have recently grown more positive on the company's outlook.
While the new $475 target is lower than the average analyst target of $557, it still suggests the stock could rise about 19 percent from its current level. This wave of upgrades reflects a view that the company is well-positioned as more tech giants design their own custom AI chips using its software tools.
Source: Wells Fargo
Management consistently sets a bar they can clear, beating their own profit targets in seven of the last eight quarters while growing revenue at a fast 42 percent clip.
| Expectation | |
|---|---|
| EPS | $4.11 |
| Revenue | $2.56B |